Prelude Therapeutics, Inc. (PRLD)
4.53
-0.17
(-3.62%)
USD |
NASDAQ |
Apr 27, 16:00
4.64
+0.11
(+2.43%)
After-Hours: 18:10
Prelude Therapeutics Total Liabilities (Quarterly) : 72.68M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Incyte Corp. | 1.803B |
| Niagen Bioscience, Inc. | 29.87M |
| Immunome, Inc. | 48.84M |
| Sana Biotechnology, Inc. | 265.84M |
| Moderna, Inc. | 3.688B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 141.32M |
| Shareholders Equity (Quarterly) | 68.64M |
| Debt to Equity Ratio | 0.2592 |
| Current Ratio | 1.994 |
| Net Debt Paydown Yield | 0.04% |